We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » Public Citizen Calls for FDA Resignations Over New Alzheimer’s Drug Aduhelm
Public Citizen Calls for FDA Resignations Over New Alzheimer’s Drug Aduhelm
As the first infusion of Biogen’s newly approved Alzheimer’s drug Aduhelm was given to a patient in Rhode Island, advocacy group Public Citizen called for the resignations of FDA officials, including Acting FDA Commissioner Janet Woodcock, claiming “the indefensible approval” of the drug showed “a stunning disregard for science.”